［1］BEN-DAVID U,BEROUKHIM R,GOLUB TR.Genomic evolution of cancer models: perils and opportunities［J］.Nat Rev Cancer,2019,19(2):97-109.
［2］BAR-EPHRAIM YE,KRETZSCHMAR K,CLEVERS H.Organoids in immunological research［J］. Nat Rev Immunol,2020,20(5):279-293.
［3］ACKERMANN T,TARDITO S.Cell culture medium formulation and its implications in cancer metabolism［J］.Trends Cancer,2019,5(6):329-332.
［4］TAKEBE T,WELLS JM.Organoids by design［J］.Science,2019,364(6444):956-959.
［5］DROST J,CLEVERS H.Organoids in cancer research［J］.Nat Rev Cancer,2018,18(7):407-418.
［6］ROWE RG,DALEY GQ.Induced pluripotent stem cells in disease modelling and drug discovery［J］.Nat Rev Genet,2019,20(7):377-388.
［7］DUTTON JS,HINMAN SS,KIM R,et al.Primary cell-derived intestinal models:recapitulating physiology［J］.Trends Biotechnol,2019,37(7):744-760.
［8］VLACHOGIANNIS G,HEDAYAT S,VATSIOU A,et al.Patient-derived organoids model treatment response of metastatic gastrointestinal cancers［J］.Science,2018,359(6378):920-926.
［9］MERENDA A,FENDERICO N,MAURICE MM.Wnt signaling in 3D:Recent advances in the applications of intestinal organoids［J］.Trends Cell Biol,2020,30(1):60-73.
［10］KOIKE H,IWASAWA K,OUCHI R,et al.Modelling human hepato-biliary-pancreatic organogenesis from the foregut-midgut boundary［J］.Nature,2019,574(7776):112-116.
［11］MULLENDERS J,DE JONGH E,BROUSALI A,et al.Mouse and human urothelial cancer organoids:A tool for bladder cancer research［J］.Proc Natl Acad Sci USA,2019,116(10):4567-4574.
［12］CANCER M,HUTTER S,HOLMBERG KO,et al.Humanized stem cell models of pediatric medulloblastoma reveal an Oct4/mTOR axis that promotes malignancy［J］.Cell Stem Cell,2019,25(6):855-870.
［13］DRIEHUIS E,VAN HOECK A,MOORE K,et al.Pancreatic cancer organoids recapitulate disease and allow personalized drug screening［J］.Proc Natl Acad Sci USA,2019,116 (52):26580-26590.
［14］PURNELL BA,LAVINE M.Approximating organs［J］.Science,2019,364(6444):946-947.
［15］DUTTON JS,HINMAN SS,KIM R,et al.Primary cell-derived intestinal models:recapitulating physiology［J］.Trends Biotechnol,2019,37(7):744-760.
［16］CHAN AS,YAN HHN,LEUNG SY.Breakthrough moments:organoid models of cancer［J］.Cell Stem Cell,2019,24(6):839-840.
［17］VLACHOGIANNIS G,HEDAYAT S,VATSIOU A,et al.Patient-derived organoids model treatment response of metastatic gastrointestinal cancers［J］.Science,2018,359(6378):920-926.
［18］NEAL JT,LI X,ZHU J,et al.Organoid modeling of the tumor immune microenvironment［J］.Cell,2018,175(7):1972-1988.
［19］LAVINE MS.More-realistic tumor models［J］.Science,2019,363(6429):832-833.
［20］KELLY BE,BHATTACHARYA I,HEIDARI H,et al.Volumetric additive manufacturing via tomographic reconstruction［J］.Science,2019,363(6431):1075-1079.
［21］PARK SE,GEORGESCU A,HUH D.Organoids-on-a-chip［J］.Science,2019,364(6444):960-965.
［22］TACHIBANA CY.Stem-cell culture moves to the third dimension［J］.Nature,2018,558(7709):329-331.
［23］YI HG,JEONG YH,KIM Y,et al.A bioprinted human-glioblastoma-on-a-chip for the identification of patient-specific responses to chemoradiotherapy［J］.Nat Biomed Eng,2019,3(7):509-519.
［24］YIN H,XUE W,ANDERSON DG.CRISPR-Cas:a tool for cancer research and therapeutics［J］.Nat Rev Clin Oncol,2019,16(5):281-295.
［25］TUVESON D,CLEVERS H.Cancer modeling meets human organoid technology［J］.Science,2019,364(6444):952-955.
［26］TAKEDA H,KATAOKA S,NAKAYAMA M,et al.CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes［J］.Proc Natl Acad Sci USA,2019,116(31):15635-15644.
［27］LUN ZR,LAI DH,WEN YZ,et al.Cancer in the parasitic protozoans Trypanosoma brucei and Toxoplasma gondii［J］.Proc Natl Acad Sci USA,2015,112(29):8835-8842.
［28］CHATTERJEE D,DENG WM.Drosophila model in cancer:an introduction［J］.Adv Exp Med Biol,2019,1167:1-14.
［29］BENHRA N,BARRIO L,MUZZOPAPPA M,et al.Chromosomal instability induces cellular invasion in epithelial tissues［J］.Dev Cell,2018,47(2):161-174.
［30］STEWART E,FEDERICO SM,CHEN X,et al.Orthotopic patient-derived xenografts of paediatric solid tumours［J］.Nature,2017,549(7670):96-100.
［31］YAN C,BRUNSON DC,TANG Q,et al.Visualizing engrafted human cancer and therapy responses in immunodeficient zebrafish［J］.Cell,2019,177(7):1903-1914.
［32］SALSMAN J,DELLAIRE G.Precision genome editing in the CRISPR era［J］.Biochem Cell Biol,2017,95(2):187-201.
［33］HE L,TIAN DA,LI PY,et al.Mouse models of liver cancer:Progress and recommendations［J］.Oncotarget,2015,6(27):23306-23322.
［34］GOMEZ JA,BEITNERE U,SEGAL DJ.Live-animal epigenome editing:convergence of novel techniques［J］.Trends Genet,2019,35(7):527-541.
［35］SONTHEIMER-PHELPS A,HASSELL BA,INGBER DE.Modelling cancer in microfluidic human organs-on-chips［J］.Nat Rev Cancer,2019,19(2):65-81.
［36］WEST J,NEWTON PK.Cellular interactions constrain tumor growth［J］.Proc Natl Acad Sci USA,2019,116(6):1918-1923.
［37］GRANDCLAUDON M,PERROT-DOCKE SM,TRICHOT C,et al.A quantitative multivariate model of human dendritic cell-T helper cell communication［J］.Cell,2019,179(2):432-447.
［38］CLARKE MA,FISHER J.Executable cancer models:successes and challenges［J］.Nat Rev Cancer,2020,20(6):343-354.
［39］张百红,岳红云.肿瘤研究的新方法学［J］.西北国防医学杂志,2016,37(2):117-120.
ZHANG BH,YUE HY.New methods in cancer research［J］.Med J NDFNC,2016,37(2):117-120.